Magle Chemoswed Holding AB (publ) (STO:MAGLE)
4.460
+0.620 (16.15%)
Apr 10, 2026, 5:07 PM CET
Magle Chemoswed Holding AB Employees
Magle Chemoswed Holding AB had 140 employees as of December 31, 2025. The number of employees decreased by 7 or -4.76% compared to the same quarter last year.
Employees
140
Change
-7
Growth
-4.76%
Revenue / Employee
2.00M SEK
Profits / Employee
-1.11M SEK
Market Cap
92.10M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 140 | -7 | -4.76% |
| Sep 30, 2025 | 144 | -3 | -2.04% |
| Jun 30, 2025 | 158 | 11 | 7.48% |
| Mar 31, 2025 | 145 | 67 | 85.90% |
| Dec 31, 2024 | 147 | 69 | 88.46% |
| Sep 30, 2024 | 147 | 69 | 88.46% |
| Dec 31, 2023 | 78 | 3 | 4.00% |
| Dec 31, 2022 | 75 | 6 | 8.70% |
| Dec 31, 2021 | 69 | 1 | 1.47% |
| Sep 30, 2021 | 68 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IRLAB Therapeutics AB | 31 |
| Biovica International AB | 24 |
| AcouSort AB | 16 |
| Alligator Bioscience AB | 11 |
| Spago Nanomedical AB | 7 |
| Alzinova AB | 5 |
| Simris Group AB (PUBL) | 5 |
| Annexin Pharmaceuticals AB | 4 |